SCHEMBL19695910

SCHEMBL19695910

O=C(O)c1ccncc1NC(=O)C1CC1c1ccc(OC(F)F)c(OC(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 8/20 0.42
▸ ROCK2 O75116 3/20 0.41
▸ LTB4R Q15722 1/20 0.41
▸ NAMPT P43490 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ KDM4D Q6B0I6 2/20 0.39
▸ PDE4A P27815 2/20 0.39
▸ PDE4B Q07343 2/20 0.39
▸ PDE4C Q08493 2/20 0.39
▸ PDE4D Q08499 2/20 0.39
▸ KDM6B O15054 2/20 0.37
▸ KDM5A P29375 1/20 0.37
▸ KDM5B Q9UGL1 1/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ JAK3 P52333 1/20 0.37
▸ ROCK1 Q13464 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2947337 0.86 LTB4R (0.48) LTB4RALDH1A1PDE4APDE4BPDE4C
SCHEMBL19695908 0.82 LTB4R (0.36) ROCK2LTB4RNAMPTALDH1A1LMNA
SCHEMBL15396768 0.79 ROCK2 (0.45) KDM4CROCK2NAMPTALDH1A1LMNA
SCHEMBL2950213 0.74 FFAR1 (0.43) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL2950480 0.70 LTB4R (0.61) LTB4RALDH1A1HTTSMN1; SMN2PDE4D
SCHEMBL9607119 0.69 LTB4R (0.48) ROCK2LTB4RNAMPTALDH1A1LMNA
SCHEMBL19695907 0.69 LTB4R (0.52) LTB4RALDH1A1HTTSMN1; SMN2PDE4D
SCHEMBL19695909 0.69 LTB4R (0.52) LTB4RALDH1A1HTTSMN1; SMN2PDE4D
SCHEMBL3932211 0.68 KDM4C (0.44) KDM4CALDH1A1LMNAGAAKDM4D
SCHEMBL16703135 0.67 KDM4C (0.58) KDM4CKDM4DKDM6BKDM5AKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3485883-A1 METHODS OF TREATING EYE DISEASES ASSOCIATED WITH INFLAMMATION AND VASCULAR PROLIFERATION OccuRx Pty Ltd (AU) 2019-05-22 — — EP disclosed
US-9839640-B2 Methods of treating eye diseases associated with inflammation and vascular proliferation OCCURX PTY LTD (AU) 2017-12-12 — — US disclosed
Send feedback